Finland Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kinvey Strategy eBook Kinvey answers 7 critical questions about creating your mobile strategy and technology policies. See our answers in this free eBook. From our sponsors

Finland Pharmaceuticals and Healthcare Report Q4 2013 Oct 16th 2013, 00:00, by swapnil BMI View: We anticipate further price erosions mechanisms will be introduced to the Finnish pharmaceutical market. Mimicking the strategy adopted by governments across Europe, Finland has identified the pharmaceuticals industry as a focus for cost containment, due to the relative ease with which governments can target the sector rather than pursuing less politically controversial cuts such as drastically reducing healthcare provision. However, an ageing population, a preference for patented medicines, ongoing government R&D investment and an excellent regulatory environment will ensure stable growth in the pharmaceutical market. Headline Expenditure Projections ? Pharmaceuticals: EUR2.92bn (US$3.70bn) in 2012 to EUR2.96bn (US$3.94bn) in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120562. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/finland-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions